Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06518928 · ClinicalTrials.gov registry record
SprmPik AI Sperm Selection Study SiD, an Assistant for Sperm Selection During Intracytoplasmic Sperm Injection in Medically Assisted Reproduction: Effect on Fertilization, Blastocyst Formation, Early Pregnancy Loss, and Consistent Practice. A Prospective Pilot Study.
A clinical trial of Infertility, sponsored by Ovation Fertility.
- Recruiting
- Registry status
- 155
- Enrollment target
- 2
- Study locations
NCT06518928: Recruiting study of Infertility, sponsored by Ovation Fertility.
NCT06518928 is a study of Infertility that is actively recruiting participants, run by Ovation Fertility. The registered enrollment target is 155 participants, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06518928, a study of Infertility, is actively recruiting participants, sponsored by Ovation Fertility.
- RECRUITING
- Registry status
- 155 participants
- Enrollment target
- 2
- Study locations
Study Summary
SprmPik AI Assisted Sperm Selection Study SiD, an assistant for sperm selection during intracytoplasmic sperm injection in medically assisted reproduction: effect on fertilization, blastocyst formation, early pregnancy loss, and consistent practice. A prospective pilot study.
Primary Outcome
Does SiD assist in ICSI Fertilization
Conditions Studied
Interventions
- OTHER Artificial Intelligence assisted sperm selection
Study Locations (2)
Nevada
- Ovation Fertility Las Vegas - Las Vegas
Texas
- Ovation Fertility - Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2026-10-01 |
What NCT06518928 shows while recruiting
NCT06518928 is an observational study that tracks outcomes without assigning an intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Artificial Intelligence assisted sperm selection is the first listed.
NCT06518928 reports a single indexed study location in Nevada, Texas.
Frequently Asked Questions
What is clinical trial NCT06518928 about?
NCT06518928 is a clinical study titled "SprmPik AI Sperm Selection Study SiD, an Assistant for Sperm Selection During Intracytoplasmic Sperm Injection in Medically Assisted Reproduction: Effect on Fertilization, Blastocyst Formation, Early Pregnancy Loss, and Consistent Practice. A Prospective Pilot Study.". SprmPik AI Assisted Sperm Selection Study SiD, an assistant for sperm selection during intracytoplasmic sperm injection in medically assisted reproduction: effect on fertilization, blastocyst formation, early pregnancy loss, and consistent practice. A prospective pilot study.
What is the current status of trial NCT06518928?
This trial is currently recruiting. The enrollment target is 155 participants. The study started on 2024-01-01. Estimated completion is 2026-10-01.
What conditions does trial NCT06518928 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT06518928?
The interventions under investigation include: Artificial Intelligence assisted sperm selection (OTHER).
Who is sponsoring clinical trial NCT06518928?
This trial is sponsored by Ovation Fertility, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06518928 being conducted?
This trial has 2 study locations across Nevada, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06518928's enrollment target sits among peer trials
155 47th of 74 higher than 28 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
-
Discarded Materials Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI